The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services Scientific, Architectural And Engineering Technical Activities Scientific Research And Development 72.11 - Research and experimental development on biotechnology
200 jobs Number of planned job creations
Announcement Date
18 August 2020
Employment effect (start)
18 August 2020
Foreseen end date
Description
As announced on 18 August 2020, the German biotechnology company Curevac will open 200 new jobs in Germany. Curevac, which went public last week, is currently working on a vaccine for COVID-19 and plans to grow quickly. Consequently, most of the jobs will be located at the headquarters of the company in Tübingen.
Curevac is mainly looking for bio and chemical technicians, quality managers, scientists and administration support.
Currently, the company has 484 employees worldwide; 471 working in Germany and 13 in the USA.
Eurofound (2020), Curevac, Business expansion in Germany, factsheet number 101532, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101532.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
